Clinical trial research at Willamette Valley Cancer Institute and Research Center (WVCI) was published January in the New England Journal of Medicine (NEJM), marking the second time in six months cancer research at WVCI appeared in the presitigous journal. Read more.
In July 2013, the Medicare Patient Access to Cancer Treatment Act (H.R. 2869), a bipartisan bill, was introduced to remedy a flawed Medicare payment policy that pays more to hospitals than cancer care centers for the same care. This legislation would equalize reimbursements for cancer treatments regardless of whether a service is delivered in the hospital or a physician office. We encourage you to reach out to your Representatives and encourage them to cosponsor the Medicare Patient Access to Cancer Treatment Act. Read more.
Dr. Jeff Sharman, a hematologist oncologist at Willamette Valley Cancer Institute and Research Center, was published in the New England Journal of Medicine last week for clinical trials held at WVCI on a breakthrough drug for chronic lymphocytic leukemia (CLL). Read more.
Dr. Ben Cho, medical oncology director at WVCI, was voted president-elect by the Oregon Society of Medical Oncology (OSMO) at its May 18th meeting in Ashland. As president-elect, Dr. Cho is slated to assume the presidency in May 2015. Read more.
"This study was attractive because the drug was oral, and patients don't have to come into the center. They can take it from home," Dr. Wendland says. Read more.